Aakaar Medical Technologies Ltd.

•

aakaarmedical.inBSE: -NSE: AAKAAR

Market Cap₹ 88 Cr.

Current Price

High / Low₹ 96 / 46

Stock P/E13.2

Book Value₹ 38

Price to Book1.25

Dividend Yield0.00 %

ROCE18.5 %

ROE17.1 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Aesthetic Products: 89.0% • Aesthetic Devices & Device Consumables: 11.0%

AI Sector View

AI GENERATED

Oil Gas & Consumable Fuels

Reduce

Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.

Confidence

78%

View full sector analysis →

PROS

Company has a good return on equity (ROE) track record: 3 Years ROE 25.6%
Company has a healthy return on capital (ROCE) of 22.8%
Operating margins have improved to 15.4% from 11.0%
Attractively priced for its growth - PEG of 0.3
Company maintains a comfortable, low leverage position
Company comfortably covers its interest (6.1x coverage)

CONS

Operating cash flow has been negative in recent years
Receivables are growing faster than sales - a possible quality concern
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -1.40x)
Free cash flow has been persistently negative
Working capital days have increased from 130 to 287 days

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Oil Gas & Consumable FuelsTradingTrading

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	ADANIENT	2894.80	52.64	391875.62	0.04	-1461.54	-249.67	32923.98	49.92	13.30	15.57
2.	PREMIERENE	999.50	27.25	45372.45	0.10	471.92	53.32	2462.59	35.25	33.72	29.03
3.	CPPLUS	3715.75	92.10	43957.48	0.04	142.20	332.51	1402.42	89.51	29.48	14.52
4.	AEGISLOG	1242.80	34.86	43622.28	0.70	544.84	210.70	2356.86	37.07	19.76	30.28
5.	REDINGTON	363.00	16.68	28378.41	1.65	453.49	94.65	34922.47	34.57	18.96	2.03
6.	HONASA	470.45	61.63	15337.81	0.64	90.45	118.87	755.95	27.00	8.99	14.58
7.	LLOYDSENT	70.95	96.45	10830.89	0.21	109.98	-55.77	563.03	70.15	12.84	18.07
8.	SGMART	825.65	83.70	10406.10	0.00	455.80	1310.71	13085.70	1044.08	10.43	4.49
9.	MMTC	62.14	20.84	9321.00	0.00	104.24	135.52	0.68	-50.00	33.46	-1423.53
10.	ENTERO	1799.70	62.46	7832.85	0.00	52.05	72.17	1940.50	38.23	10.93	5.00
11.	CELLO	346.70	24.48	7658.08	0.43	73.40	-8.99	526.72	-0.43	17.15	18.80
12.	AAKAAR	62.00	13.24	87.87	0.00	—	—	—	—	18.45	—

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

No quarterly results found

We don't have this information yet. Please check back later.

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	19	33	46	62	67
	17	29	41	52	57
Operating Profit	2	4	5	10	11
OPM %	13	11	11	16	17
Other Income	0	0	0	0	1
Interest	0	0	1	2	2
Depreciation	0	0	0	0	0
	2	3	4	8	9
Tax %	27	31	26	26	28
Net Profit	2	2	3	6	7
EPS	2	2	41	6	5
Dividend Payout %	35	24	0	0	0
Minority Interest	0	0	0	0	0
Share of Associates	0	0	0	0	0
Adjusted EPS	2	2	3	6	5

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 27%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 46%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: -30%

RETURN ON EQUITY

10 Years:: —
5 Years:: 24%
3 Years:: 26%
Last Year:: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
LIABILITIES	-	-	-	-	-
Equity Capital	1	1	1	10	14
	7	9	12	13	40
	4	6	15	23	19
Trade Payables	2	3	2	4	2
	4	5	5	6	4
Total Liabilities	18	23	35	56	79
ASSETS	-	-	-	-	-
	0	0	0	0	0
	7	11	14	15	20
	0	0	16	28	37
Cash & Bank	2	0	0	6	16
	8	11	4	7	5
Total Assets	18	23	35	56	79
Total Debt	4	6	15	23	19
Net Working Capital	8	9	12	22	53
Contingent Liabilities	0	0	1	0	0
Book Value per Share	114.67	137.93	178.94	22.32	38.49
Face Value	10.00	10.00	10.00	10.00	10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0	-3	-8	-5	-8
Cash from Investing	-0	-0	-0	-0	0
Cash from Financing	-1	1	8	11	19
	-1	-2	0	5	10
Free Cash Flow	0	-3	-8	-5	-9
OCF / Net Profit	0.30	-1.36	-2.80	-0.90	-1.26
Cumulative 5-Year FCF	0	0	0	0	0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	23.12	30.76	41.00	5.79	4.68
Book Value (₹)	114.67	137.93	178.94	22.32	38.49
Dividend per Share (₹)	8.00	7.50	0.00	0.00	0.00
Cash EPS (₹)	1.72	2.35	3.15	5.91	4.77
PROFITABILITY
Operating Margin %	12.53%	11.05%	10.84%	15.86%	15.40%
Net Margin %	8.31%	6.57%	6.22%	9.80%	9.91%
ROE %	20.16%	24.35%	25.88%	33.72%	17.06%
ROCE %	20.40%	25.81%	23.29%	26.69%	18.45%
	9.09%	10.56%	9.94%	13.33%	9.85%
EFFICIENCY
Debtor Days	104	88	105	131	178
Inventory Days	131	102	101	85	93
Payable Days	65	50	38	37	35
	171	139	168	179	236
FINANCIAL HEALTH
Debt to Equity (x)	0.48x	0.61x	1.20x	0.98x	0.34x
Interest Coverage (x)	11.32x	8.21x	4.42x	5.75x	6.12x
	1.83x	1.72x	1.59x	1.73x	3.21x
GROWTH
Revenue Growth %	0.00%	68.43%	40.65%	33.55%	8.74%
Operating Profit Growth %	0.00%	48.54%	42.40%	92.85%	11.75%
Net Profit Growth %	0.00%	33.04%	33.30%	110.18%	10.03%
	0.00%	0.00%	33.30%	-85.88%	-19.09%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	10.27x
P/B (x)	0.00x	0.00x	0.00x	0.00x	1.25x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	3.00x	2.78x	6.34x

Shareholding Pattern

Numbers in percentages

	Sep 2025	Mar 2026
	67.01	67.05
	0.50	0.00
	10.73	11.17
Government	0.00	0.00
	21.77	21.78

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for AAKAAR

Loading news…

🤖

AI Stock Analyst

Aakaar Medical Technologies Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

ADANIENT

2894.80

52.64

391875.62

0.04

-1461.54

-249.67

32923.98

49.92

13.30

15.57

PREMIERENE

999.50

27.25

45372.45

0.10

471.92

53.32

2462.59

35.25

33.72

29.03

CPPLUS

3715.75

92.10

43957.48

0.04

142.20

332.51

1402.42

89.51

29.48

14.52

AEGISLOG

1242.80

34.86

43622.28

0.70

544.84

210.70

2356.86

37.07

19.76

30.28

REDINGTON

363.00

16.68

28378.41

1.65

453.49

94.65

34922.47

34.57

18.96

2.03

HONASA

470.45

61.63

15337.81

0.64

90.45

118.87

755.95

27.00

8.99

14.58

LLOYDSENT

70.95

96.45

10830.89

0.21

109.98

-55.77

563.03

70.15

12.84

18.07

SGMART

825.65

83.70

10406.10

0.00

455.80

1310.71

13085.70

1044.08

10.43

4.49

MMTC

62.14

20.84

9321.00

0.00

104.24

135.52

0.68

-50.00

33.46

-1423.53

ENTERO

1799.70

62.46

7832.85

0.00

52.05

72.17

1940.50

38.23

10.93

5.00

CELLO

346.70

24.48

7658.08

0.43

73.40

-8.99

526.72

-0.43

17.15

18.80

AAKAAR

62.00

13.24

87.87

0.00

—

18.45

—

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Operating Profit

OPM %

Other Income

Interest

Depreciation

Tax %

Net Profit

EPS

Dividend Payout %

Minority Interest

Share of Associates

Adjusted EPS

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

LIABILITIES

Equity Capital

Trade Payables

Total Liabilities

ASSETS

Cash & Bank

Total Assets

Total Debt

Net Working Capital

Contingent Liabilities

Book Value per Share

114.67

137.93

178.94

22.32

38.49

Face Value

10.00

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-3

-8

-5

-8

Cash from Investing

-0

Cash from Financing

-1

-2

Free Cash Flow

-3

-8

-5

-9

OCF / Net Profit

0.30

-1.36

-2.80

-0.90

-1.26

Cumulative 5-Year FCF

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

23.12

30.76

41.00

5.79

4.68

Book Value (₹)

114.67

137.93

178.94

22.32

38.49

Dividend per Share (₹)

8.00

7.50

0.00

Cash EPS (₹)

1.72

2.35

3.15

5.91

4.77

PROFITABILITY

Operating Margin %

12.53%

11.05%

10.84%

15.86%

15.40%

Net Margin %

8.31%

6.57%

6.22%

9.80%

9.91%

ROE %

20.16%

24.35%

25.88%

33.72%

17.06%

ROCE %

20.40%

25.81%

23.29%

26.69%

18.45%

9.09%

10.56%

9.94%

13.33%

9.85%

EFFICIENCY

Debtor Days

104

105

131

178

Inventory Days

131

102

101

Payable Days

171

139

168

179

236

FINANCIAL HEALTH

Debt to Equity (x)

0.48x

0.61x

1.20x

0.98x

0.34x

Interest Coverage (x)

11.32x

8.21x

4.42x

5.75x

6.12x

1.83x

1.72x

1.59x

1.73x

3.21x

GROWTH

Revenue Growth %

0.00%

68.43%

40.65%

33.55%

8.74%

Operating Profit Growth %

0.00%

48.54%

42.40%

92.85%

11.75%

Net Profit Growth %

0.00%

33.04%

33.30%

110.18%

10.03%

0.00%

33.30%

-85.88%

-19.09%

VALUATION

P/E (x)

0.00x

10.27x

P/B (x)

0.00x

1.25x

Dividend Yield %

0.00%

0.00x

3.00x

2.78x

6.34x

Sep 2025

Mar 2026

67.01

67.05

0.50

0.00

10.73

11.17

Government

0.00

21.77

21.78

Aakaar Medical Technologies Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Aakaar Medical Technologies Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI